Potential of e- and m-health tools and gender-tailored approach in modern model of education and prevention of cardiovascular disease in women
 
More details
Hide details
1
Silesian Center for Heart Diseases in Zabrze, Poland
 
2
Silesian Park of Medical Technology Kardio-Med Silesia, Zabrze, Poland
 
3
Department of Internal Medicine, School of Public Health in Bytom, Medical University of Silesia, Katowice, Poland
 
 
Corresponding author
Joanna Małgorzata Zembala-John   

Silesian Center for Heart Diseases in Zabrze, ul. M. Curie-Skłodowskiej 9, 41-800 Zabrze, Poland
 
 
Ann. Acad. Med. Siles. 2018;72:184-192
 
KEYWORDS
TOPICS
ABSTRACT
Cardiovascular disease (CVD) is a leading cause of death worldwide. Only in 2012 it accounted for 17.5 million deaths. Although it affects both sexes, every year more women die due to CVD, more than due to all cancers, tuberculosis, HIV/AIDS and malaria combined. The risk factors, symptoms and course of CVD in women and men often differ, which makes early proper diagnosis and treatment more difficult. Despite being a major threat for women, the level of awareness and knowledge on the gender- -specific picture of CVD, both among females and within the medical environment, remains staggeringly low. Introducing a new gender-tailored health education and prevention model, adjusted to the medical, socio-cultural, technological expectations and needs of contemporary women, to their modern lifestyle and pace of life, could constitute an attractive and more effective alternative to initiatives undertaken so far targeting the general population. E- and m-health tools seem to have a promising potential in educating and supporting contemporary women in their everyday health management. Applying Internet-based solutions together with a gender-oriented approach could increase the level of knowledge and CVD awareness among women, lead to improvement of their heart health and contribute to a reduction in the medical-social-economic burden of CVD in women.
 
REFERENCES (62)
1.
Global Status Report on non-communicable diseases; World Heart Organization; Geneva 2014: 9.
 
2.
Nicholas M., Townsend N., Scarborough P., Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014; 35(42): 2950–2959, doi: 10.1093/eurheartj/ehu299.
 
3.
The burden of cardiovascular disease and diabetes. W: OECD (2015), Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care. OECD Health Policy Studies, OECD Publishing, Paris 2015: 31–49, doi: 10.1787/9789264233010-en.
 
4.
Oficjalna strona Eurostat – Statistics Explained. Eurostat – Statistics Explained > Causes of death statistics. http://ec.europa.eu/eurostat/s... [dostęp: 10.05.2017].
 
5.
Wilkins E., Wilson L., Wickramasinghe K., Bhatnagar P., Leal J., Luengo-Fernandez R., Burns R., Rayner M., Townsend N. European Cardiovascular Disease Statistics 2017. European Heart Network, Brussels 2017: 7–8.
 
6.
Mendis S., Puska P., Norrving B. Evidence for prevention of heart attack and stroke. W: Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization (in collaboration with the World Heart Federation and World Stroke Organization), Geneva 2011: 16–18.
 
7.
Smith S.C. Jr., Collins A., Ferrari R., Holmes D.R. Jr, Logstrup S., McGhie D.V., Ralston J., Sacco R.L., Stam H., Taubert K., Wood D.A., Zoghbi W.A. Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). J. Am. Coll. Cardiol. 2012; 60(22): 2343–2348, doi: 10.1016/j.jacc.2012.08.962.
 
8.
Anand S. A commitment to curbing the pandemic of cardiovascular diseases. Lancet. 2000; 356 (9226): 347, doi: 10.1016/S0140-6736(05)73636-9.
 
9.
Chockalingam A., Balaguer-Vintro I., Achutti A., de Luna A.B., Chalmers J., Farinaro E., Lauzon R., Martin I., Papp J.G., Postiglione A., Reddy K.S., Tse T.F. The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. Can. J. Cardiol. 2000; 16(2): 227–229.
 
10.
Cierniak-Piotrowska M., Marciniak G., Stańczak J. Statystyka zgonów i umieralności z powodu chorób układu krążenia. W: Strzelecki Z., Szymborski J. (red). Zachorowalność i umieralność na choroby układu krążenia a sytuacja demograficzna Polski. Rządowa Rada Ludnościowa, Warszawa 2015: 46–80.
 
11.
Czarnecka D. Choroby układu krążenia u kobiet. W: Ostrowska A. (red.). Zdrowie i jego zagrożenia. Raport Polki 2013. Fundacja MSD dla zdrowia kobiet, Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny, Warszawa 2014: 26–31.
 
12.
Oficjalna strona Eurostatu – Statistics Explained. Eurostat – Statistics Explained > Causes of death statistics > Figure 4: Deaths from ischemic heart. Disease – standardised death rate, 2014 (per 100.000 inhabitants). http:// ec.europa.eu/eurostat/statisticsexplained/index.php/File:Deaths_from_ischaemic_heart_diseases__standardised_death_rate,_2014_(per_100_000_inhabitants)_YB17.png [dostęp: 22.05.2017].
 
13.
Oficjalna strona World Heart Federation. World Heart Federation > Resources for Women. Hypertension. https://www.world-heart-federa... [dostęp: 22.05.2017].
 
14.
Gholizadeh L, Davidson P. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int. 2008; 29(1): 3–22, doi: 10.1080/07399330701723756.
 
15.
Mehta L.S., Beckie T.M., DeVon H.A., Grines C.L., Krumholz H.M., Johnson M.N., Lindley K.J., Vaccarino V., Wang T.Y., Watson K.E., Wenger N.K. Acute Myocardial Infarction in Women. A Scientific Statement From the American Heart Association. Circulation 2016; 133(9): 916–947, doi: 10.1161/CIR.0000000000000351.
 
16.
Oficjalna strona World Heart Federation. World Heart Federation > Women and CVD – facts and tips. https://www.world-heart-federa... [dostęp: 09.10.2017].
 
17.
Kornacewicz-Jach Z., Olszowska M., Kopeć G. et al. Wytyczne Polskiego Forum Profilaktyki dotyczące profilaktyki chorób sercowo-naczyniowych u kobiet. Oficjalna strona Polskiego Forum Profilaktyki Chorób Układu Krążenia: http://www.pfp.edu.pl/wytyczne... [dostęp: 10.2017].
 
18.
Sallam T., Watson K.E. Predictors of cardiovascular risk in women. Women’s Health 2013; 9(5): 491–498, doi: 10.2217/whe.13.44.
 
19.
Czarnecka D., Jankowski P. Choroby układu krążenia. W: Ostrowska A. (red.). Raport Polki 50+. Zdrowie i jego zagrożenia. Fundacja MSD dla Zdrowia Kobiet, Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny, Warszawa 2015: 25–29.
 
20.
Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am. Heart J. 1986. Feb; 111(2): 383–390.
 
21.
Johnston N., Schenck-Gustafsson K., Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? Eur. Heart J. 2011; 32: 1331–1336, doi: 10.1093/eurheartj/ehr009.
 
22.
Rosenfeld A.G. Treatment-Seeking Delay Among Women With Acute Myocardial Infarction: Decision Trajectories and Their Predictors. Nurs. Res. 2004; 53(4): 225–236.
 
23.
Nguyen H.L., Gore J.M., Saczynski J.S., Yarzebski J., Reed G., Spencer F.A., Goldberg R.J. Age and sex differences and 20-year trends (1986 to 2005) in prehospital delay in patients hospitalized with acute myocardial infarction. Circ. Cardiovasc. Qual. Outcomes 2010; 3(6): 590–598, doi: 10.1161/CIRCOUTCOMES.110.957878.
 
24.
Janion M., Janion-Sadowska A. Odrębności leczenia choroby niedokrwiennej serca u kobiet. Kardiol. Dypl. 2012; 11(11): 6–11.
 
25.
Ahmed B., Dauerman HL. Women, bleeding, and coronary intervention. Circulation 2013; 127: 641–649, doi: 10.1161/CIRCULATIONAHA.112.108290.
 
26.
Krzeminska-Pakuła M. Czy płeć żeńska jest czynnikiem ryzyka w ostrych zespołach wieńcowych? Kardiol. Pol. 2011; 69(8): 793–794.
 
27.
Mosca L., Manson J.E., Sutherland S.E., Langer R.D., Manolio T., Barrett-Connor E. Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 1997; 96(7): 2468–2482, doi: 10.1161/01.CIR.96.7.2468.
 
28.
McSweeney J.C., Rosenfeld A.G., Abel W.M., Braun L.T., Burke L.E., Daugherty S.L., Fletcher G.F., Gulati M., Mehta L.S., Pettey C., Reckelhoff J.F. Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Statement for Healthcare Professionals from the American Heart Association. Circulation 2016; 133(13): 1302–1331, doi: 10.1161/CIR.0000000000000381.
 
29.
Möller-Leimkühler A.M. Gender differences in cardiovascular disease and comorbid depression. Dialogues Clin. Neurosci. 2007; 9(1): 71–83.
 
30.
Appelman Y., van Rijn B.B., Ten Haaf M.E., Boersma E., Peters S.A. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis 2015; 241(1): 211–218, doi: 10.1016/j.atherosclerosis.2015.01.027.
 
31.
Farley T.M., Meirik O., Chang C.L., Poulter N.R. Combined oral contraceptives, smoking, and cardiovascular risk. J. Epidemiol. Community Health 1998; 52(12): 775–785.
 
32.
Zdrowie i zachowania zdrowotne mieszkańców Polski w świetle Europejskiego Ankietowego Badania Zdrowia (EHIS) 2014. Główny Urząd Statystyczny, Warszawa 2015:5. https://stat.gov.pl/obszary-te... [dostęp: 04.2017].
 
33.
Kośmicki M. Choroba niedokrwienna serca u kobiet – problemy diagnostyki i terapii. Przew. Lek. 2001; 4(11): 16–30.
 
34.
Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.T., Corrà U., Cosyns B., Deaton C., Graham I. et al. 2016 European Guidelines on cardiovascular prevention in clinical practice: the Sixths Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur. Heart J. 2016; 37(29): 2315–2381, doi: 10.1093/eurheartj/ehw106.
 
35.
Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335: 974.
 
36.
Klenk J., Keil U., Jaensch A., Christiansen M.C., Nagel G. Changes in life expectancy 1950–2010: contributions from age- and disease-specific mortality in selected countries. Popul. Health Metr. 2016; 14: 20, doi: 10.1186/s12963-016-0089-X.
 
37.
Oficjalna strona World Health Organization. World Health Organization > Data > Global Health Observatory Data > GHO themes: SDG health and health related target indicators: Mortality and global health estimates > Life expectancy at birth. http://www.who.int/gho/mortali... [dostęp: 09.10.2017].
 
38.
World Population Aging. United Nations, Department of Economic and Social Affairs, Population Division. ST/SEA/SER.A/348. New York 2013: 31–33. http://www.un.org/en/developme... [dostęp: 22.05.2017].
 
39.
Sytuacja demograficzna osób starszych i konsekwencje starzenia się ludności Polski w świetle prognozy na lata 2014–2050. Główny Urząd Statystyczny, Warszawa 2014.
 
40.
Oficjalna strona Eurostat – Statistics Explained. Eurostat > Statistics Explained > Mortality and life expectancy statistics http://ec.europa.eu/euro-stat/... [dostęp: 20.04.2017].
 
41.
Trwanie życia w 2015 r. Informacje i opracowania statystyczne. Główny Urząd Statystyczny, Departament Warszawa 2016: 15–33. https://stat.gov.pl/obszary-te... [dostęp: 12.2016].
 
42.
Wojtyniak B., Stokwiszewski J., Goryński P., Zdrojewski T. Długość życia i umieralność ludności Polski. W: Wojtyniak B., Goryński P. (red.). Sytuacja zdrowotna w Polsce i jej uwarunkowania. Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny. Warszawa 2016: 49–134.
 
43.
Oficjalna strona Eurostatu – European Commission. Eurostat > Products datasets > Healthy life years and life expectancy at birth, by sex. http://epp.eurostat.ec.europa.... [dostęp: 09.05.2017].
 
44.
Ostrowska A. Polki 2013 – zdrowie i położenie społeczne. W: Ostrowska A. (red.). Zdrowie i jego zagrożenia. Raport Polki 2013. Fundacja MSD dla zdrowia kobiet, Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny, Warszawa 2014: 9–13.
 
45.
Kornacewicz-Jach Z., Kossuth I., Czechowska M. W kolorze serca. Go red for women. Przegląd Menopauzalny 2006; 3: 142–147.
 
46.
Oficjalna strona Go Red for Women. Go Red for Women > Get involved. https://www.goredforwomen.org/... [dostęp: 20.09.2017].
 
47.
Global diffusion of eHealth: Making universal health coverage achieve-able. Report of the third global survey on eHealth. Global Observatory for eHealth; World Health Organization, Geneva 2016: 11–25; 27–53. http://apps.who.int/iris/bitst... [dostęp: 20.10.2017].
 
48.
Zielona Księga w sprawie mobilnego zdrowia („mHealth”). COM(2014)219 final. Komisja Europejska, Bruksela 2014: 3–7. http://ec.europa.eu/transpa-re... [dostęp: 10.05.2017].
 
49.
Davey S., Davey A., Singh J.V. Mobile-Health Approach: A Critical Look on Its Capacity to Augment Health System of Developing Countries. Indian J. Community Med. 2014; 39(3): 178–182, doi: 10.4103/0970-0218.137160.
 
50.
2015 Global health care sector outlook. Common goals, competing priorities. Deloitte, 2015: 12. https://www2.deloitte.com/cont... [dostęp: 20.07.2017].
 
51.
Taylor K. Connected health: how digital technology is transforming health and social care. The Deloitte Centre for Health Solutions, London 2015; 14–15, 18–22. https://www2.deloitte.com/cont... [dostęp: 10.10.2017].
 
52.
mHealth. W: From innovation to implementation. eHealth in the WHO European Region. World Health Organization, Copenhagen 2016: 40–51.
 
53.
mHealth devices and services – analysis Global mHealth devices and services market 2016–2022. Zion Market Research. Deerfield Beach 2016: 25–27.
 
54.
mHealth App Developer Economics 2016. The current status and trends of the mHealth app market. Research2Guidance, Berlin 2016: 12–15. https://research2guidance.com/... [dostęp: 10.2017].
 
55.
Oficjalna strona Statista – The Statistics Portal. Smartphone users worldwide 2014–2020. https://www.statista.com/stati... [dostęp: 20.09.2017].
 
56.
Olok G.T., Yagos W.O., Ovuga E. Knowledge and attitudes of doctors towards e-health use in healthcare delivery in government and private hospitals in Northern Uganda: a cross-sectional study. BMC Med. Inform. Decis. Mak. 2015; 15: 87, doi:10.1186/s12911-015-0209-8.
 
57.
Beratarrechea A., Lee A.G., Willner J.M., Jahangir E., Ciapponi A., Rubinstein A. The Impact of Mobile Health Interventions on Chronic Disease Outcomes in Developing Countries: A Systematic Review. Telemed. J. E Health 2014; 20(1): 75–82, doi: 10.1089/tmj.2012.0328.
 
58.
Socio-economic impact of mHealth. An assessment report for European Union. GSMA. PWC 2013; 4–5, 8–13.
 
59.
European Public Health Alliance Briefing on mobile Health (mHealth). European Public Health Alliance. Brussels 2013: 12–15.
 
60.
Problemy. W: Zielona Księga w sprawie mobilnego zdrowia („mHealth”). COM(2014)219 final. Komisja Europejska, Bruksela 2014: 8–20.
 
61.
Mobile medical application. Guidance for Industry, Food and Drug Administration Staff. U.S. Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiological Health, Center for Biologics Evaluation and Research. Feb. 9, 2015: 4–18.
 
62.
mHealth – New horizons for health through mobile technologies. Global Observatory for eHealth series – Volume 3: 1–7.
 
eISSN:1734-025X
Journals System - logo
Scroll to top